DEUTSCHE BANK AG\

Bank

Position in AVTX — Avalo Therapeutics, Inc.

CIK 948046 FRANKFURT AM MAIN, 2M

Position in AVTX

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$760,747

-$1,478,753 QoQ

Shares Held

41,166

-72.6% QoQ

Ownership

0.077%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#78

of 126 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 1% Shared 0% None 99%

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. AVTX ranks #155 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,579,110	$784,391,303
2	REGN	Regeneron Pharmaceuticals, Inc.	518,409	$323,248,743
3	ALNY	Alnylam Pharmaceuticals, Inc.	815,400	$245,459,858
4	RVMD	Revolution Medicines, Inc.	888,019	$166,308,196
5	RPRX	Royalty Pharma plc	2,717,951	$152,395,510
6	INCY	Incyte Corp	1,262,988	$143,172,312
7	ARGX	Argenx SE	137,335	$127,415,291
8	LGND	Ligand Pharmaceuticals Inc	249,611	$78,899,539

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$760,747	41,166	-72.6%	Shares	Defined	2026-08-07
2026-03-31	$2,239,500	150,000	0.0%	Shares	Defined	2026-05-06
2025-12-31	$2,724,000	150,000	+32.8%	Shares	Defined	2026-02-11
2022-03-31	$81,870	112,925	+188.1%	Shares	Defined	2022-05-13
2021-12-31	$66,642	39,202	+23.3%	Shares	Defined	2022-02-16
2021-09-30	$69,310	31,794	—	Shares	Defined	2021-11-04
2021-06-30 CERC	—	32,833	+33.8%	Shares	Defined	2021-08-11
2021-03-31 CERC	—	24,536	-8.5%	Shares	Defined	2021-05-13
2020-12-31 CERC	—	26,813	+37.4%	Shares	Defined	2021-02-16
2020-09-30 CERC	—	19,518	+33.5%	Shares	Defined	2020-11-12
2020-06-30 CERC	—	14,623	-28.0%	Shares	Defined	2020-08-13
2020-03-31 CERC	—	20,303	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.